牟田 真理子
| 健康メディカル学部 健康栄養学科 | 教授 |
Last Updated :2025/06/19
■研究者基本情報
■経歴
経歴
学歴
- 2001年04月 - 2004年03月, 共立薬科大学大学院, 薬学研究科, 博士後期課程
- 2001年04月 - 2004年03月, 共立薬科大学, Graduate School, Division of Pharmaceutical Sciences, Doctor
- 1999年04月 - 2001年03月, 共立薬科大学大学院, 薬学研究科, 博士前期課程
- 1999年04月 - 2001年03月, 共立薬科大学, Graduate School, Division of Pharmaceutical Sciences, Master
- 1980年04月 - 1984年03月, 日本女子大学, 家政学部, 食物学科管理栄養士専攻
- 1980年04月 - 1984年03月, 日本女子大学, Faculty of Home Economics
■研究活動情報
受賞
論文
- 栄養教諭による食育の必要性
牟田 真理子
帝京平成大学池袋キャンパス教職研究, 2017年03月, ［査読有り］ - Basic Fibroblast Growth Factor Is Essential to Maintain Endothelial Progenitor Cell Phenotype in TR-BME2 Cells
Yoshimichi Sai; Tomohiro Nishimura; Mariko Muta; Hisashi Iizasa; Takashi Miyata; Emi Nakashima
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2014年04月, ［査読有り］ - Genome-wide copy number analysis in primary breast cancer
Takayuki Ueno; Mitsuru Emi; Hidenori Sato; Noriko Ito; Mariko Muta; Katsumasa Kuroi; Masakazu Toi
EXPERT OPINION ON THERAPEUTIC TARGETS, 2012年03月, ［査読有り］ - Genome-wide copy number analysis in primary breast cancer
Takayuki Ueno; Mitsuru Emi; Hidenori Sato; Noriko Ito; Mariko Muta; Katsumasa Kuroi; Masakazu Toi
EXPERT OPINION ON THERAPEUTIC TARGETS, 2012年03月, ［査読有り］ - Roles of TauT and system A in cytoprotection of rat syncytiotrophoblast cell line exposed to hypertonic stress
T. Nishimura; Y. Sai; J. Fujii; M. Muta; H. Iizasa; M. Tomi; M. Deureh; N. Kose; E. Nakashima
PLACENTA, 2010年11月, ［査読有り］ - Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells
Mariko Muta; Tomonori Yanagawa; Yoshimichi Sai; Shigehira Saji; Eiji Suzuki; Tomoyuki Aruga; Katsumasa Kuroi; Gaku Matsumoto; Masakazu Toi; Emi Nakashima
ONCOLOGY, 2009年, ［査読有り］ - A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients
Eiji Suzuki; Rinpei Niwa; Shigehira Saji; Mariko Muta; Makiko Hirose; Shigeru Iida; Yukimasa Shiotsu; Mitsuo Satoh; Kenya Shitara; Masahide Kondo; Masakazu Toi
CLINICAL CANCER RESEARCH, 2007年03月, ［査読有り］ - Altered expression of basement membrane-related molecules in rat brain pericyte, endothelial, and astrocyte cell lines after transforming growth factor-beta 1 treatment
Noriko Kose; Tomoko Asashima; Mariko Muta; Hisashi Iizasa; Yoshimichi Sai; Tetsuya Terasaki; Emi Nakashima
DRUG METABOLISM AND PHARMACOKINETICS, 2007年, ［査読有り］ - ラット脳周皮細胞, 内皮細胞, アストロサイトにおける Transforming growth factor-β1 (TGF-β1) に応答する基底膜関連物質の発現解析
KOSE Noriko; ASASHIMA Tomoko; MUTA Mariko; IIZASA Hisashi; SAI Yoshimichi; TERASAKI Tetsuya; NAKASHIMA Emi
Drug metabolism and pharmacokinetics, 2007年, ［査読有り］ - Tumor size significantly correlates with postoperative liver metastases and COX-2 expression in patients with resectable pancreatic cancer
Gaku Matsumoto; Mariko Muta; Koji Tsuruta; Shinichiro Horiguchi; Katsuyuki Karasawa; Atsutake Okamoto
PANCREATOLOGY, 2007年, ［査読有り］ - Mechanical analysis of tumor growth regression by the cyclooxygenase-2 inhibitor, DFU, in a Walker256 rat tumor model: Importance of monocyte chemoattractant protein-1 modulation
M Muta; G Matsumoto; E Nakashima; M Toi
CLINICAL CANCER RESEARCH, 2006年01月, ［査読有り］ - Enhancement of the caspase-independent apoptotic sensitivity of pancreatic cancer cells by DHMEQ, an NF-kappa B inhibitor
G Matsumoto; M Muta; K Umezawa; T Suzuki; K Misumi; K Tsuruta; A Okamoto; M Toi
INTERNATIONAL JOURNAL OF ONCOLOGY, 2005年11月, ［査読有り］ - Targeting of nuclear factor kappa B pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: Antitumor and antiangiogenic potential in vivo
G Matsumoto; J Namekawa; M Muta; T Nakamura; H Bando; K Tohyama; M Toi; K Umezawa
CLINICAL CANCER RESEARCH, 2005年02月, ［査読有り］ - DFU, a selective COX-2 inhibitor, suppresses MCF-7 xenograft tumor growth in mice
G Matsumoto; MA Rahman; M Muta; T Nakamura; H Bando; S Saji; K Tsuruta; A Okamoto; M Toi
ONCOLOGY REPORTS, 2004年08月, ［査読有り］ - Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer
M Toi; H Bando; S Horiguchi; M Takada; A Kataoka; T Ueno; S Saji; M Muta; N Funata; S Ohno
BRITISH JOURNAL OF CANCER, 2004年06月, ［査読有り］ - Study of cancer gene therapy using IL-12-secreting endothelial progenitor cells in a rat solid tumor model
M Muta; G Matsumoto; K Hiruma; E Nakashima; M Toi
ONCOLOGY REPORTS, 2003年11月, ［査読有り］ - Impact of vasculogenesis on solid tumor growth in a rat model
M Muta; G Matsumoto; K Hiruma; S Saji; E Nakashima; M Toi
ONCOLOGY REPORTS, 2003年09月, ［査読有り］ - Survival benefit of KRN7000 immune therapy in combination with TNP470 in hamster liver metastasis model of pancreatic cancer
G Matsumoto; S Nagai; M Muta; K Tsuruta; A Okamoto; M Toi
ONCOLOGY REPORTS, 2003年09月, ［査読有り］ - Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues
Y Yamamoto; JI Yamashita; M Toi; M Muta; S Nagai; N Hanai; A Furuya; Y Osawa; S Saji; M Ogawa
ONCOLOGY REPORTS, 2003年07月, ［査読有り］ - Expression of macrophage migration inhibitory factor in human breast cancer: Association with nodal spread
H Bando; G Matsumoto; M Bando; M Muta; T Ogawa; N Funata; J Nishihira; M Koike; M Toi
JAPANESE JOURNAL OF CANCER RESEARCH, 2002年04月, ［査読有り］ - Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer
M Toi; H Bando; T Ogawa; M Muta; C Hornig; HA Weich
INTERNATIONAL JOURNAL OF CANCER, 2002年03月, ［査読有り］ - Establishment of bone marrow-derived endothelial cell lines from ts-SV40 T-antigen gene transgenic rats
K Hattori; M Muta; M Toi; H Iizasa; M Shinsei; T Terasaki; M Obinata; M Ueda; E Nakashima
PHARMACEUTICAL RESEARCH, 2001年01月, ［査読有り］ - Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer
T Ueno; M Toi; H Saji; M Muta; H Bando; K Kuroi; M Koike; H Inadera; K Matsushima
CLINICAL CANCER RESEARCH, 2000年08月, ［査読有り］ - Significance of membrane type 1 matrix metalloproteinase expression in breast cancer
S Ishigaki; M Toi; T Ueno; H Matsumoto; M Muta; M Koike; M Seiki
JAPANESE JOURNAL OF CANCER RESEARCH, 1999年05月, ［査読有り］ - Significance of membrane type 1 matrix metalloproteinase expression in breast cancer
Shinsuke Ishigaki; Masakazu Toi; Takayuki Ueno; Hiroshi Matsumoto; Mariko Muta; Morio Koike; Motoharu Seiki
Japanese Journal of Cancer Research, 1999年, ［査読有り］ - Role of MDM2 overexpression in doxorubicin resistance of breast carcinoma
A Suzuki; M Toi; Y Yamamoto; S Saji; M Muta; T Tominaga
JAPANESE JOURNAL OF CANCER RESEARCH, 1998年02月, ［査読有り］
講演・口頭発表等
- 食品群別摂取量と咬合圧･咀嚼能力の関連についての検討～若齢成人を対象として～
与島優希; 尾崎哲則; 山田恒代; 牟田真理子; 小川万紀子
第61回日本栄養改善学会学術総会, 2014年08月22日 - Potential beneficial effects of ginger on chemotherapy in breast cancer.
Mariko Muta; Takayuki Ueno; Katsumasa Kuroi; Masakazu Toi
The 8th Annual Conference of OOTR, 2012年04月20日 - がん化学療法に対するショウガによる効果の検討
牟田真理子; 上野貴之; 黒井克昌; 戸井雅和
第69回日本癌学会学術総会, 2010年09月23日 - Effects of ginger on cancer chemotherapy
牟田 真理子
The 6th Annual Conference of OOTR, 2010年02月26日 - Effects of paclitaxel and docetaxel on endothelial progenitor cells in a rat tumor model.
The 8th Cerebral Vascular Biology International Conference, 2009年 - Effects of paclitaxel and docetaxel on endothelial progenitor cells in a rat tumor model.
The 8th Cerebral Vascular Biology International Conference, 2009年 - Docetaxel, Paclitaxelの血管内皮前駆細胞への作用と血管新生阻害効果の検討。
第12回がん分子標的治療研究会総会, 2008年06月26日 - Inhibition of Vasculogenesis on Endothelial Progenitor Cell Line TR-BME by Docetaxel and Paclitaxel.
The 4th Annual Conference of Organisation for Oncology and Translational Research (OOTR), 2007年 - Inhibition of Vasculogenesis on Endothelial Progenitor Cell Line TR-BME by Docetaxel and Paclitaxel.
The 4th Annual Conference of Organisation for Oncology and Translational Research (OOTR), 2007年 - 脈管形成が固形腫瘍に及ぼす血管新生促進効果とMCP-1の関与
第64回日本癌学会総会, 2005年 - 血管内皮前駆細胞の腫瘍特異的集積におけるVEGF, MCP-1の関与
第63回日本癌学会総会, 2004年 - IL-12遺伝子導入血管内皮前駆細胞の腫瘍特異的集積性と癌治療効果
第６２回日本癌学会総会, 2003年 - Study of cancer gene therapy using IL-12-secreting endothelial progenitor cells in a rat solid tumor model.
AAPS Annual Meeting and Exposition, 2003年 - Study of cancer gene therapy using IL-12-secreting endothelial progeitor cells in a rato solid tumor model.
AAPS Annual Meeting and Exposition, 2003年 - 脈管形成と免疫による腫瘍増殖の調節
第６１回日本癌学会総会, 2002年 - Tumor-targeting of cell therapy using gene-transfected endothelial progenitor cells.
The 1st Korea-Japan Joint Symposium on Drug Delivery and Therapy, 2002年 - Tumor-targeting of cell therapy using gene-transfected endothelial progenitor cells.
The 1st Korea-Japan Joint Symposium on Drug Delivery and Therapy., 2002年 - ラット骨髄由来血管内皮前駆細胞株の生体内動態と腫瘍血管新生への関与
第６０回日本癌学会総会, 2001年 - Recruitment of bone marrow-derived endothelial cells to the in vivo malignant tumor by comparison with other organs.
World Congress of Pharmacy and Pharmaceutical Sciences 2001., 61st International Congress of FIP., 2001年 - Recruitment of bone marrow-derived endothelial cells to the in vivo malignant tumor by comparison with other organs.
World Congress of Pharmacy and Pharmaceutical Sciences 2001., 61th International Congress FIP., 2001年 - Established of conditionally immortalized endothelial cell lines (TR-BME) derived from rat bone marrow.
Millennial world congress of pharmaceutical sciences., 2000年 - Established of conditionally immortalized endothelial cell lines (TR-BME) derived from rat bone marrow.
Millennial world congress of pharmaceutical sciences., 2000年
共同研究・競争的資金等の研究課題
